A Marie Sklodowska-Curie COFUND programme coordinated by @sysbioire | #PrecisionOncology | Funded by the EU Horizon2020 Research & Innovation Programme
DevelopMed works to accelerate researcher career development with prestigious Fellowships & training opportunities. Today at #ICSB25, we’re hosting a media communications workshop, led by sci-com experts Claire O'Connell & Elaine Burke @claireoconnell@CriticalRedPen
🧑💼👏Our postdoc, Dr. Michela Coan (@CoanMichela), and PhD student, Bhavya Dhaka, showcased their research at #RNAbench2bedside in CA, USA this week!
🧬 Their presentations highlighted the potential of #lncRNAs as next-generation targeted cancer therapies.
@NatureConf
Thanks to @sysbioire for organising a superb Oral Presentation skills workshop, and to @craigslattery for giving such a great overview of how to communicate with different audiences. A great learning experience for all of our @DevelopMed_MSCA fellows
Say hello to our next cohort of researchers who will be involved in our 2024 CuriosiTY Programme 👋🏻
Day 2 of Public Engagement training complete ✅
There are already some fantastic ideas for activities to carry out with the TY students. Can't wait to see them!
Congratulations to POI researcher Prof. Afshin Samali for his recognition in the 2023 Highly Cited Researchers 2023 list from Clarivate @Afshin_Samali@CURAMdevices
The lab tours were a huge hit! So happy to have the opportunity to welcome all Invisible Spectrum attendees to tour the labs, observe expert demonstrations and meet some of the researchers. Thanks to all the tour guides and demonstrators
We are so proud of our groundbreaking @PrecisionOncIre programme and the impactful work they do, both in research and public engagement! #InvisibleSpectrum
Our Forward-looking panel session today brings together representatives from #funding bodies in the US, Ireland & Northern Ireland/UK as we discuss opportunities for international #collaboration & what funding supports are available. @theNCI@QUBCancerProf@QBI_UCSF#QBISBI2023
Delighted to have Daniel Gallahan, Director of the National Cancer Institute's Division of Cancer Biology, giving our final talk today. "NCI's efforts in Cancer Systems Biology: the next phase," starting now! #QBISBI2023#funding@QBI_UCSF@theNCI@UCD_Research@PrecisionOncIre